Monte Rosa Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · Boston, MA, United States
- PrincipalsFilip JankuChief Medical OfficerJennifer ChampouxChief Operating OfficerMarkus WarmuthPresident & CEOand 3 more
- CompanyMonte Rosa Therapeutics, Inc.Boston, MA, United States
- Phone line+1 (617) 949-2643General business
Monte Rosa Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker GLUE) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 6
Chief executive
Markus WarmuthPresident & CEO
Operations
Jennifer ChampouxChief Operating Officer
Legal
Philip NicksonChief Business & Legal Officer
Everyone else on file (3)
Filip JankuChief Medical Officer
Sharon TownsonChief Scientific Officer
Edmund DunnPrincipal Accounting Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Filip Janku — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Markus Warmuth — President & CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Jennifer Champoux — Chief Operating Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sharon Townson — Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Crispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capability